AZTA logo

AZTA
Azenta Inc

1,370
Mkt Cap
$1.19B
Volume
825,202.00
52W High
$41.73
52W Low
$19.87
PE Ratio
-20.44
AZTA Fundamentals
Price
$25.91
Prev Close
$25.11
Open
$25.45
50D MA
$24.15
Beta
1.43
Avg. Volume
1.03M
EPS (Annual)
-$1.22
P/B
0.70
Rev/Employee
$197,940.33
$1,030.39
Loading...
Loading...
News
all
press releases
Azenta, Inc. (NASDAQ:AZTA) Given Consensus Rating of "Hold" by Brokerages
Azenta, Inc. (NASDAQ:AZTA - Get Free Report) has earned a consensus rating of "Hold" from the eight brokerages that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Azenta (AZTA) Stock Drops 13% After-Hours What's Happening?
Azenta stock falls after-hours following SEC Form 3 filing showing no beneficial ownership.read more...
Benzinga·8d ago
News Placeholder
Massachusetts Financial Services Co. MA Makes New Investment in Azenta, Inc. $AZTA
Massachusetts Financial Services Co. MA purchased a new position in Azenta, Inc. (NASDAQ:AZTA - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,106,536 shares of the co...
MarketBeat·10d ago
News Placeholder
Azenta (NASDAQ:AZTA) Shares Acquired Rep. Gilbert Ray Cisneros, Jr.
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Azenta, Inc. (NASDAQ:AZTA). In a filing disclosed on April 07th, the Representative disclosed that they had bought between $1,001 and $15,000 in Azenta stock on March 3rd. The trade occurred in the Representat...
MarketBeat·16d ago
News Placeholder
Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis...
PR Newswire·18d ago
News Placeholder
Allspring Global Investments Holdings LLC Raises Position in Azenta, Inc. $AZTA
Allspring Global Investments Holdings LLC lifted its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 7.8% during the fourth quarter, according to the company in its most recent Form...
MarketBeat·23d ago
News Placeholder
Azenta (NASDAQ:AZTA) Shares Gap Up - Still a Buy?
Azenta (NASDAQ:AZTA) Shares Gap Up - Here's What Happened...
MarketBeat·25d ago
News Placeholder
Assenagon Asset Management S.A. Increases Stock Holdings in Azenta, Inc. $AZTA
Assenagon Asset Management S.A. increased its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 249.4% in the 4th quarter, according to the company in its most recent disclosure with...
MarketBeat·26d ago
News Placeholder
Azenta (NASDAQ:AZTA) Sets New 52-Week Low - Here's Why
Azenta (NASDAQ:AZTA) Sets New 52-Week Low - Here's Why...
MarketBeat·29d ago
News Placeholder
Azenta, Inc. (NASDAQ:AZTA) Receives Average Recommendation of "Hold" from Analysts
Azenta, Inc. (NASDAQ:AZTA - Get Free Report) has received a consensus rating of "Hold" from the eight brokerages that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned...
MarketBeat·29d ago
<
1
2
...
>

Latest AZTA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.